To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Kallikrein-related peptidase 5 (KLK5); KLK7; KLK14; suppression of tumorigenicity 14 (ST14; matriptase)

Dermatology

INDICATION: Dermatology

In vitro and mouse studies have identified coumarin-3-carboxylate-based protease inhibitors that could help

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE